drugset / Trial / NCT01509391
Keyhole Limpet Hemocyanin in Chronic Hepatitis C
NaSingle-groupOpen-labelTreatment
Summary
In this study the investigators examine the safety and efficacy of Keyhole-limpet-hemocyanin in patients with chronic hepatitis c infection and liver cirrhosis. The investigators hypothesize that administration of keyhole-limpet-hemocyanin reduces the viral load in patients infected with hepatitis c.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | keyhole limpet hemocyanin | Vaccine | — | Subcutaneous |